Diakonos Oncology
Phase 2Diakonos is a clinical-stage biotech company developing groundbreaking Dendritic Cell Vaccines for difficult-to-treat cancers.
Founded
2019
Focus
Cell & Gene Therapy
About
Diakonos is a clinical-stage biotech company developing groundbreaking Dendritic Cell Vaccines for difficult-to-treat cancers.
Funding History
2Series AUndisclosedUndisclosedJun 15, 2021
SeedUndisclosedUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2019
LocationHouston, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile